Medicure, Inc. (NASDAQ:MCUJF) | WebDisclosure

Basculer en Français

10457	Companies
219659	Keywords
149031	Articles
116147	Press releases

Home
Companies
Medicure, Inc.

PRESS RELEASE

published on 10/25/2024 at 00:00, 1 year 7 months ago

Medicure Announces Positive Settlement of Product Development and Supply Contracts
Medicure Inc. settles a product development and supply contract with a third party, receiving €1.5 million. Details remain confidential. Company focuses on pharmaceuticals and healthcare products in the U.S. market

Pharmaceuticals Medicure Inc. Product Development Healthcare Products Supply Contract
BRIEF

published on 08/14/2024 at 23:35, 1 year 9 months ago

Medicure finalise l'acquisition de la propriété intellectuelle de CanAm Bioresearch

Propriété Intellectuelle Acquisition De MediCure Recherche Biologique CanAm Développement Thérapeutique Actifs Pharmaceutiques
BRIEF

published on 08/14/2024 at 23:35, 1 year 9 months ago

Medicure Completes Acquisition of Intellectual Property from CanAm Bioresearch

Intellectual Property CanAm Bioresearch Medicure Acquisition Therapeutic Development Pharmaceutical Assets
PRESS RELEASE

published on 08/14/2024 at 23:30, 1 year 9 months ago

Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
Medicure Inc. acquires intellectual property assets of CanAm Bioresearch Inc. related to new chemical entities for therapeutic use. Agreement terms and related party transaction details provided

Medicure Inc. New Chemical Entities Therapeutic Use CanAm Bioresearch Inc. Intellectual Property Assets
BRIEF

published on 08/14/2024 at 23:05, 1 year 9 months ago

Medicure publie ses résultats financiers pour le trimestre clos le 30 juin 2024

Résultats Financiers Medicure AGGRASTAT ZYPITAMAG Drogue Marley
BRIEF

published on 08/14/2024 at 23:05, 1 year 9 months ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024

Financial Results Marley Drug Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 08/14/2024 at 23:00, 1 year 9 months ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024
Medicure Inc. reports Q2 2024 financial results: net revenue down, EBITDA negative, net loss recorded. AGGRASTAT and ZYPITAMAG sales impacted. Analyst call on Aug 15, 2024

Financial Results EBITDA Medicure Inc. Net Loss Q2 2024
BRIEF

published on 06/24/2024 at 23:05, 1 year 11 months ago

Medicure Announces Acquisition Agreement with CanAm Bioresearch Inc.

Pharmaceuticals Intellectual Property Asset Purchase Medicure CanAm Bioresearch
BRIEF

published on 06/24/2024 at 23:05, 1 year 11 months ago

Medicure annonce un accord d'acquisition avec CanAm Bioresearch Inc.

Médicament Propriété Intellectuelle Médicaments CanAm Biorecherche Achat D'actifs
PRESS RELEASE

published on 06/24/2024 at 23:00, 1 year 11 months ago

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use

Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use

Accesswire

Published on 05/27/2026 at 02:10, 5 hours ago

Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Published on 05/27/2026 at 01:45, 5 hours 25 minutes ago

Organto Foods Announces Record First Quarter 2026 Financial Results
Published on 05/27/2026 at 00:25, 6 hours 45 minutes ago

Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Published on 05/26/2026 at 22:15, 8 hours 55 minutes ago

LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Published on 05/26/2026 at 22:01, 9 hours 9 minutes ago

Kidoz Inc. Reports Q1 2026 Financial Results with YoY Revenue Growth, Accelerating Strategic Investment in AI

View all ACCESSWIRE

EQS Group

Published on 05/27/2026 at 06:00, 1 hour 10 minutes ago

Verve Group Reports Solid Organic Growth in the First Quarter, Along with Strong Operating Performance and Significant Cash Flow Growth
Published on 05/26/2026 at 18:50, 12 hours 19 minutes ago

The AI Gold Rush Is Running Into a Margin Problem
Published on 05/26/2026 at 18:30, 12 hours 40 minutes ago

H2APEX publishes financial figures for the first quarter of 2026 and confirms forecast
Published on 05/26/2026 at 17:45, 13 hours 25 minutes ago

FIGEAC AÉRO: EXTENSION DU PARTENARIAT AVEC UN CLIENT AMÉRICAIN
Published on 05/26/2026 at 17:30, 13 hours 40 minutes ago

GEVELOT S.A.: Weekly declaration of share buybacks – 05/26/2026 (French only)

Les Echos

Published on 05/26/2026 at 18:39, 12 hours 30 minutes ago

Déclaration des opérations d'achats d'actions réalisées le 18 mai 2026
Published on 05/26/2026 at 18:39, 12 hours 30 minutes ago

Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 13 hours 25 minutes ago

EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Published on 05/26/2026 at 17:45, 13 hours 25 minutes ago

EURAZEO INVESTIT DANS BABYLON, SPÉCIALISTE FRANÇAIS DES APARTHOTELS DE NOUVELLE GÉNÉRATION
Published on 05/26/2026 at 17:40, 13 hours 30 minutes ago

LDC : Nombre total de droits de vote et d'actions composant le capital au 30.04.26.

View all LES ECHOS COMFI WIRE